Annual ROE
24.83%
-4.44%-15.17%
December 31, 2024
Summary
- As of March 12, 2025, STK annual return on equity is 24.83%, with the most recent change of -4.44% (-15.17%) on December 31, 2024.
- During the last 3 years, STK annual ROE has fallen by -5.35% (-17.73%).
- STK annual ROE is now -17.73% below its all-time high of 30.18%, reached on December 31, 2021.
Performance
STK ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
STK ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.2% | - |
| 3 y3 years | -17.7% | - |
| 5 y5 years | - | - |
STK ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.7% | +157.1% | ||
| 5 y | 5-year | -17.7% | +157.1% | ||
| alltime | all time | -17.7% | +157.1% |
Columbia Seligman Premium Technology Growth Fund ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | 24.83%(-15.2%) | - |
| Dec 2023 | 29.27%(-167.3%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -43.52%(-244.2%) | - |
| Dec 2021 | 30.18% | - |
FAQ
- What is Columbia Seligman Premium Technology Growth Fund annual return on equity?
- What is the all time high annual ROE for Columbia Seligman Premium Technology Growth Fund?
- What is Columbia Seligman Premium Technology Growth Fund annual ROE year-on-year change?
What is Columbia Seligman Premium Technology Growth Fund annual return on equity?
The current annual ROE of STK is 24.83%
What is the all time high annual ROE for Columbia Seligman Premium Technology Growth Fund?
Columbia Seligman Premium Technology Growth Fund all-time high annual return on equity is 30.18%
What is Columbia Seligman Premium Technology Growth Fund annual ROE year-on-year change?
Over the past year, STK annual return on equity has changed by -4.44% (-15.17%)